Glucagon-like peptide 1 (GLP-1) agonists are a class of drugs that are approved by the FDA for weight loss in obese people without diabetes or to treat type 2 diabetes
Each mL contains cyanocobalamin 1000 mcg, sodium chloride, and benzyl alcohol in water for injection
Another method, topical formulations, acts topically on the skin
When considering 5-Amino-1MQ as a therapeutic intervention, individualized dosing based on body weight, formulation type, and specific health goals should be determined in consultation with a qualified healthcare provider familiar with this compounds mechanisms and applications
GLP-1 therapy helps regulate insulin, stabilize blood sugar levels, and reduce fat storage, contributing to better energy levels, mood, and overall well-being
Wegovy was approved to treat obesity in 2021